<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Loss-of-function mutations in the ATP-binding cassette (ABCA)-1 gene locus are the underlying cause for <z:e sem="disease" ids="C1704429" disease_type="Disease or Syndrome" abbrv="FHA|HDLC|HDLD">familial hypoalphalipoproteinemia</z:e>, providing a human isolated low-<z:chebi fb="17" ids="39025">HDL</z:chebi> model </plain></SENT>
<SENT sid="1" pm="."><plain>In these <z:e sem="disease" ids="C1704429" disease_type="Disease or Syndrome" abbrv="FHA|HDLC|HDLD">familial hypoalphalipoproteinemia</z:e> subjects, we evaluated the impact of isolated low <z:chebi fb="17" ids="39025">HDL</z:chebi> on endothelial function and the vascular effects of an <z:hpo ids='HP_0011009'>acute</z:hpo> increase in <z:chebi fb="17" ids="39025">HDL</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: In 9 ABCA1 heterozygotes and 9 control subjects, vascular function was assessed by venous occlusion plethysmography </plain></SENT>
<SENT sid="3" pm="."><plain>Forearm blood flow responses to the endothelium-dependent and -independent <z:chebi fb="1" ids="35620">vasodilators</z:chebi> <z:chebi fb="19" ids="28790">serotonin</z:chebi> (<z:chebi fb="0" ids="28790">5HT</z:chebi>) and <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi>, respectively, and the inhibitor of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase NG-monomethyl-l-arginine (<z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) were measured </plain></SENT>
<SENT sid="4" pm="."><plain>Dose-response curves were repeated after systemic infusion of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I/<z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi> (apoA-I/PC) disks </plain></SENT>
<SENT sid="5" pm="."><plain>At baseline, ABCA1 heterozygotes had decreased <z:chebi fb="17" ids="39025">HDL</z:chebi> levels (0.4+/-0.2 mmol/L; P&lt;0.05), and their forearm blood flow responses to both <z:chebi fb="0" ids="28790">5HT</z:chebi> (maximum, 49.0+/-10.4%) and <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> (maximum, -22.8+/-22.9%) were blunted compared with control subjects (both P&lt; or =0.005) </plain></SENT>
<SENT sid="6" pm="."><plain>Infusion of apoA-I/PC disks increased plasma <z:chebi fb="17" ids="39025">HDL</z:chebi> to 1.3+/-0.4 mmol/L in ABCA1 heterozygotes, which resulted in complete restoration of vasomotor responses to both <z:chebi fb="0" ids="28790">5HT</z:chebi> and <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> (both P&lt;/=0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Endothelium-independent vasodilation remained unaltered throughout the protocol </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In ABCA1 heterozygotes, isolated low <z:chebi fb="17" ids="39025">HDL</z:chebi> is associated with <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, attested to by impaired basal and stimulated NO bioactivity </plain></SENT>
<SENT sid="9" pm="."><plain>Strikingly, both parameters were completely restored after a single, rapid infusion of apoA-I/PC </plain></SENT>
<SENT sid="10" pm="."><plain>These findings indicate that in addition to its long-term role within reverse cholesterol transport, <z:chebi fb="17" ids="39025">HDL</z:chebi> per se also exerts direct beneficial effects on the arterial wall </plain></SENT>
</text></document>